Skip to content
Recall Observatory FDA recall evidence

Drug product

Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.

D-003-2013

August 21, 2012

Class II

Product summary

Firm
Caraco Pharmaceutical Laboratories Ltd.
Event
Event 63031
Status
Terminated
Classification
Class II
Quantity
a) 2424 Cartons b) 2675 Cartons
Official record key
drug-enforcement:D-003-2013

Official wording

Reason: Crystallization: Presence of crystals of Nimodipine within the capsule solution.

Code information: Lot: a) 3305.039B, Exp 07/13; b) 3305.039A, Exp 07/13

Distribution pattern: One direct account - Caraco Pharmaceutical Labroatories, LTD Detroit, Michigan 78 sub accounts

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Crystallization: Presence of crystals of Nimodipine within the capsule solution.